Cargando…
The hazards and risks of inhaled poorly soluble particles – where do we stand after 30 years of research?
BACKGROUND: In 2006, titanium dioxide and carbon black were classified by IARC as “possibly carcinogenic to humans” and in 2017 the European Chemicals Agency’s (ECHA) Committee for Risk Assessment concluded titanium dioxide meets the criteria to be classified as suspected of causing cancer (category...
Autores principales: | Borm, Paul J. A., Driscoll, Kevin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383218/ https://www.ncbi.nlm.nih.gov/pubmed/30791931 http://dx.doi.org/10.1186/s12989-019-0294-4 |
Ejemplares similares
-
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005) -
Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021) -
Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021) -
Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013) -
Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017)